With this funding, our foremost goal is to advance the development of the next generation of peptide antibiotics that effectively target both Gram-positive and Gram-negative bacteria.
With this funding, our foremost goal is to advance the development of the next generation of peptide antibiotics that effectively target both Gram-positive and Gram-negative bacteria.